Produkty 1617-68-1

CAS 1617-68-1 występuje w naszej ofercie pod nazwami: Lupeol acetate, Lupeol acetate, (1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-Hexamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-yl acetate, Lupeol acetate, 98.0%, Lupeol acetate, min. 95 %, 2 mg. Oferty producentów: GLPBio, TargetMol, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 10mg, 5mg, 2mg, 25mg, 50mg, 5 mg, 10 mg.

Lupeol acetate
GLPBio
  • opakowanie: 1mg, 10mg, 5mg
  • Warianty: 3
od 625,12
Zobacz produkt
Lupeol acetate
TargetMol, Biosynth
  • opakowanie: 10mg, 2mg, 5mg, 25mg
  • Warianty: 6
od 2464,51
Zobacz produkt
(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-Hexamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-yl acetate
Chemat
  • opakowanie: 1mg, 10mg, 5mg, 25mg
  • Warianty: 4
od 323,60
Zobacz produkt
Lupeol acetate, 98.0%
MedChemExpress
  • opakowanie: 5 mg, 10 mg
  • Warianty: 2
od 1081,31
Zobacz produkt
Lupeol acetate, min. 95 %, 2 mg
Roth
  • opakowanie: 2mg
  • Warianty: 1
od 825,94
Zobacz produkt
Lupeol acetate, min. 95 %, 5 mg
Roth
  • opakowanie: 5mg
  • Warianty: 1
od 1297,90
Zobacz produkt
Lupeol acetate, min. 95 %, 10 mg
Roth
  • opakowanie: 10mg
  • Warianty: 1
od 2024,71
Zobacz produkt
Lupeol acetate, min. 95 %, 25 mg
Roth
  • opakowanie: 25mg
  • Warianty: 1
od 3091,34
Zobacz produkt
Lupeol acetate (Standard)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Lupeol acetate, 98%
Fluorochem
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 487,35
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate (CAS 1617-68-1) to związek chemiczny o wzorze sumarycznym C32H52O2 i masie molowej 468.8 g/mol. Nazwa systematyczna IUPAC: [(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate. InChIKey: ODSSDTBFHAYYMD-YOJQYFTNSA-N.

Dane identyfikacyjne
Wzór sumarycznyC32H52O2
Masa molowa468.8 g/mol
Nazwa IUPAC[(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate
InChIKeyODSSDTBFHAYYMD-YOJQYFTNSA-N
SMILESCC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Lupeol acetate, LUPENYL ACETATE, 3-Acetyllupeol, 3-O-Acetyllupeol, Lupeyl acetate, Lup-20(29)-en-3-ol, acetate, (3beta)-, lupeol 3-acetate, Lup-20(29)-en-3.beta.-ol, acetate, Lup-20(29)-en-3-ol, acetate, (3.beta.)-, lupenol acetate
Izomery (ten sam wzór sumaryczny)
[(3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-yl] acetate C32H52O2
[(3S,4aR,6aS,6aR,6bR,8aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,6a,7,8,9,10,13,14,14a-tetradecahydropicen-3-yl] acetate C32H52O2
[(3S,4aR,6aR,6aR,6bR,8aS,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,6a,7,8,9,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl] acetate C32H52O2
[(3S,4aR,6aR,6aR,6bR,8aR,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-1,2,3,4a,5,6,6a,7,8,9,10,12,12a,13,14,14a-hexadecahydropicen-3-yl] acetate C32H52O2
[(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C32H52O2
[(3S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl] acetate C32H52O2
dotriaconta-14,17,20,23,26,29-hexaenoic acid C32H52O2
[(3S,4aR,6aR,6aS,8aR,12aR,14aR,14bR)-4,4,6a,6a,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl] acetate C32H52O2
[(3S,4aR,6aR,6bS,8aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicen-3-yl] acetate C32H52O2
[(3S,5R,8R,9R,10R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C32H52O2
[(1R,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-[(2R)-6-methylhept-5-en-2-yl]-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] acetate C32H52O2
[(3R,3aR,5aR,5bS,9S,11aS,11bR,13aS,13bR)-3a,5a,8,8,11b,13a-hexamethyl-3-propan-2-yl-1,2,3,4,5,5b,6,9,10,11,11a,12,13,13b-tetradecahydrocyclopenta[a]chrysen-9-yl] acetate C32H52O2